Blaz Lupse
Bremen, HB 28359, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The Hippo terminal effector YAP boosts enterovirus replication in type 1 diabetes.
Journal: Nature communications
Published: July 07, 2023
PHLPP1 deletion restores pancreatic β-cell survival and normoglycemia in the db/db mouse model of obesity-associated diabetes.
Journal: Cell death discovery
Published: October 26, 2021
LDHA is enriched in human islet alpha cells and upregulated in type 2 diabetes.
Journal: Biochemical and biophysical research communications
Published: June 17, 2021
Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes.
Journal: Cell reports
Published: October 28, 2020
The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis.
Journal: Nature communications
Published: May 11, 2020
Matrix Metalloproteinase-3 is Key Effector of TNF-α-Induced Collagen Degradation in Skin.
Journal: International journal of molecular sciences
Published: October 10, 2019
Neratinib protects pancreatic beta cells in diabetes.
Journal: Nature communications
Published: January 19, 2019
An SCFFBXO28 E3 Ligase Protects Pancreatic β-Cells from Apoptosis.
Journal: International journal of molecular sciences
Published: March 15, 2018
Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism.
Journal: Trends in endocrinology and metabolism: TEM
Published: March 06, 2018
Last Updated: 09/26/2026